#3048
Somatostatin Analogs or Active Surveillance in Sporadic Non-Functioning Pancreatic Neuroendocrine Tumors
Introduction:
Non-functioning (NF), sporadic pancreatic neuroendocrine tumors (pNETs) have usually an indolent behavior, but sometimes show an unpredictable aggressiveness. Surgery is the first-choice for localized tumors >2 cm. Unresectable or metastatic lesions expressing somatostatin receptors (SSTRs) are treated with Somatostatin analogs (SSAs). No evidence of SSAs efficacy exists in tumors ≤2 cm, for which active surveillance has been proposed.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Authors:
Schinzari G,
Maiorano B,
Rossi E,
Bianchi A,
Chiloiro S,
Keywords:
pNET,
non-functioning,
sporadic,
somatostatin analogs,
surveillance,
#2977
Predicting Survival in Patients with a Neuroendocrine Tumor of the Small Intestine (SI-NET)
Introduction:
SI-NET comprise the largest group of neuroendocrine tumors. Because of their heterogeneity, predicting survival has proven challenging. A nomogram (NG) to assess SI-NET disease specific survival (DSS) has been developed in 2010 by Modlin, et al. based on analysis of retrospective data from the Surveillance, Epidemiology and End Results (SEER) database.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Authors:
Levy S,
van Veenendaal L,
Korse C,
Verbeek W,
Vriens M,
Keywords:
SI-NET,
Nomogram,
Survival,
#2923
Interim Analysis of Prospective Evaluation of the Management of Sporadic Nonfunctioning Asymptomatic Pancreatic Neuroendocrine Neoplasms ≤ 2 cm (ASPEN Study)
Introduction:
Guidelines recommend a watchful strategy for small, incidental, nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNEN).
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Partelli S
Authors:
Partelli S,
Zerbi A,
Massironi S,
Jin-Young J,
Landoni L,
Keywords:
small neuroendocrine pancreatic tumors,
surveillance,
surgery,
follow-up,